play a neuroprotective role (56)
GLP-1 Medications and Your Vision: Balancing the Headlines with Clinical Facts Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Mr Mfazo Hove Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, was invited by Newsweek to comment on new research linking GLP-1 medications to a rare optic nerve condition
A TFT should also be arranged after any significant weight change, as levothyroxine requirements may alter
GPx activity was stable across the two baselines ( B = 3.45, BSE = 2.77, Z = 1.25, p = 0.213), but then increased significantly to posttreatment ( B = 9.60, BSE = 3.34, Z = 2.87, p = 0.004